Newsletter | August 20, 2024

08.20.24 -- CRISPR-Cas Genome Editing For Rejuvenation Of Aging Stem Cells

FEATURED EDITORIAL

CRISPR-Cas Genome Editing For Rejuvenation Of Aging Stem Cells

As stem cells age, their regenerative capacity declines due to accumulated genetic and epigenetic changes. Using CRISPR-Cas, scientists can directly edit these changes or modulate aging-related pathways.

INDUSTRY INSIGHTS

Optimizing Virus Filtration Validation

Explore guidance regarding the effective validation of a virus filtration process in the laboratory, including the fundamentals of viral filtration and an examination of relevant regulatory guidelines.

How Approved Drugs Have Evolved Since The '70s

Drugs have become more lipophilic and complex in structure over time. Innovative strategies are needed to improve bioavailability of these new drugs.

The Power Of AI And Route Scouting To Navigate API Complexity

Using AI tools for retrosynthesis can help you investigate molecules interactively to build a complex API manufacturing process that maintains your timeline and saves you money.

The Key To Accelerating RNA-LNP Drug Development

Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.

"Ultra High” Potency Development And Manufacture

A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need.

New Technologies To Improve Solubility Of Brick Dust Compounds

David Lyon, Ph.D., and Molly Adam answer attendee questions from a recent webinar about three enabling technologies designed to improve drug solubility in organic solvents for spray drying.

MOST POPULAR NEWS

AI Can Speed Up Drug Development

New Ligand-Guided Technique Enhances Drug Development

Junshi Biosciences Announces Acceptance Of sNDA For Toripalimab

60 Degrees Pharma Provides Univ Of Kentucky With Right Of Reference To ARAKODA NDA

LENZ Therapeutics Announces Submission Of NDA To U.S. FDA For LNZ100

DNA Topoisomerase Insights Hold Potential For Drug Discovery And Plant Protection

QuEra Computing & QIC Partner To Accelerate Drug Discovery With Quantum Computing

Predictive Oncology Expands The App Of Its Live-Cell Tumor Platform

Quantiphi Strengthens AI Drug Discovery In Collaboration With Transcell

scPharmaceuticals Announces FDA Approval Of sNDA Expanding The FUROSCIX Indication

Absci Collaborates With Global Cancer Center To Discover Novel Therapeutics Using Generative AI

SOLUTIONS

Controlled Substances

High-Quality Raw Materials For Cell And Gene Therapy Manufacturing

Solid Form Services